. "2 Genetic Testing and Assessment." Assessing Genetic Risks: Implications for Health and Social Policy. Washington, DC: The National Academies Press, 1994.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Assessing Genetic Risks: Implications for Health and Social Policy
Wertz, D., and Fletcher, J. 1988. Attitudes of genetic counselors: A multinational study. American Journal of Human Genetics 42:592-600.
Wertz, D., and Fletcher, J. 1989a. An international survey of attitudes of medical geneticists toward mass screening and access to results. Public Health Reports 104(1):35-44.
Wertz, D., and Fletcher, J. 1989b. Ethical problems in prenatal diagnosis: A cross-cultural survey of medical geneticists in 18 nations. Prenatal Diagnosis 9:145-158.
Wertz, D., et al. 1990. Medical geneticists confront ethical dilemmas: Cross-cultural comparisons among 18 nations. American Journal of Human Genetics 46:1200-1213.
Wexler, N. 1992. The Tiresias complex: Huntington's disease as a paradigm of testing for late-onset disorders. FASEB Journal 6:2820-2825.
Winchester, R. 1992. Genetic determination of susceptibility and severity in rheumatoid arthritis. Annals of Internal Medicine 117:869-871.
World Federation of Neurology Research Group on Huntington's Disease. 1990. Ethical issues policy statement on Huntington's disease molecular genetics predictive test. Journal of Medical Genetics 27:34-38.
World Health Organization (WHO). 1983. Report of a WHO Working Group on Fetal Diagnosis of Hereditary Diseases. Geneva: World Health Organization.
World Health Organization Expert Panel (WHO). 1992. Risk Evaluation of Chorionic Villus Sampling. Report of an Expert Panel. Copenhagen: World Health Organization.
Yu, S., et al. 1991. Fragile X genotype characterized by an unstable region of DNA. Science 252:1179-1181.